Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-159,000
Closed -$15.6M 10703
2025
Q2
$15.6M Buy
159,000
+135,500
+577% +$12.8M ﹤0.01% 1678
2025
Q1
$2.18M Sell
23,500
-55,200
-70% -$5.09M ﹤0.01% 4218
2024
Q4
$7.15M Buy
+78,700
New +$7.23M ﹤0.01% 2229
2024
Q3
Sell
-20,000
Closed -$1.84M 9517
2024
Q2
$1.84M Buy
+20,000
New +$1.86M ﹤0.01% 4634
2023
Q1
Sell
-3,200
Closed -$267K 8942
2022
Q4
$267K Sell
3,200
-10,800
-77% -$974K ﹤0.01% 7217
2022
Q3
$1.35M Sell
14,000
-4,600
-25% -$549K ﹤0.01% 4886
2022
Q2
$1.96M Buy
18,600
+2,200
+13% +$281K ﹤0.01% 4204
2022
Q1
$2.83M Sell
16,400
-4,500
-22% -$672K ﹤0.01% 4073
2021
Q4
$3.38M Sell
20,900
-16,400
-44% -$2.64M ﹤0.01% 3490
2021
Q3
$5.56M Buy
37,300
+21,400
+135% +$4.45M ﹤0.01% 2573
2021
Q2
$3.89M Buy
15,900
+12,400
+354% +$3.25M ﹤0.01% 3076
2021
Q1
$927K Buy
3,500
+2,600
+289% +$733K ﹤0.01% 5600
2020
Q4
$264K Sell
900
-7,700
-90% -$1.97M ﹤0.01% 6585
2020
Q3
$2.03M Buy
8,600
+7,300
+562% +$1.66M ﹤0.01% 3005
2020
Q2
$258K Sell
1,300
-600
-32% -$112K ﹤0.01% 6048
2020
Q1
$349K Buy
+1,900
New +$338K ﹤0.01% 4039
2019
Q2
Sell
-3,300
Closed -$407K 5089
2019
Q1
$407K Buy
+3,300
New +$414K ﹤0.01% 3904

Other funds holding AMED

Jane Street's AMED Position: Q3 2025 in Review

Jane Street sold out of Amedisys (AMED) in Q3 2025, closing a stake of 48,371 shares — an estimated $4.76M sold.

Jane Street first reported a position in AMED in Q2 2014 and held it in 26 quarters. The position peaked at $15.5M in Q2 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Jane Street reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 48,371 Amedisys shares in Q3 2025, an estimated $4.76M.
  • Jane Street first reported a position in Amedisys in Q2 2014 and held it in 26 quarters.
  • Jane Street's Amedisys position peaked at $15.5M in Q2 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.